• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两年间 SARS-CoV-2 体液免疫和细胞免疫的长期持久性及变异株特异性调节

Long-Term Durability and Variant-Specific Modulation of SARS-CoV-2 Humoral and Cellular Immunity over Two Years.

作者信息

Matei Lilia, Chivu-Economescu Mihaela, Dragu Laura Denisa, Grancea Camelia, Bleotu Coralia, Hrișcă Raluca, Popescu Corneliu Petru, Diaconu Carmen C, Ruţă Simona Maria

机构信息

Stefan S. Nicolau Institute of Virology, 030304 Bucharest, Romania.

Romanian Academy Doctoral School, 010071 Bucharest, Romania.

出版信息

Int J Mol Sci. 2025 Aug 21;26(16):8106. doi: 10.3390/ijms26168106.

DOI:10.3390/ijms26168106
PMID:40869428
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12386724/
Abstract

There is an increasing need to understand the long-term dynamics and quality of SARS-CoV-2 immune memory-both humoral and cellular-particularly with emerging variants. This study aimed to evaluate immune durability and variant-specific modulation through a longitudinal analysis of individuals with diverse SARS-CoV-2 exposure histories, over two years after infection and/or vaccination. The study involved assessing anti-spike IgG and IgA levels over time and analyzing their relationship with neutralizing activity against both ancestral and Omicron SARS-CoV-2 variants. Persistence of T cell responses was evaluated using intracellular cytokine staining (ICS) and activation-induced marker (AIM) assays. Anti-S IgG levels remained stable over time and increased after each immune stimulation, suggesting cumulative immune memory. Neutralizing capacity correlated strongly with IgG levels, showing long-term stability for pre-Omicron variants, but a moderate decline for Omicron. CD4 and CD8 T cell responses persisted across all groups, largely unaffected by Omicron mutations. However, cytokine profiles revealed subtle, variant-dependent changes. These findings underscore the durability of cellular immunity and the comparatively reduced robustness of Omicron-specific humoral responses. Such insights are crucial for understanding long-term protection against evolving SARS-CoV-2 variants and guiding public health strategies.

摘要

越来越有必要了解严重急性呼吸综合征冠状病毒2(SARS-CoV-2)免疫记忆的长期动态和质量,包括体液免疫和细胞免疫,尤其是针对新出现的变异株。本研究旨在通过对具有不同SARS-CoV-2暴露史的个体在感染和/或接种疫苗两年后的纵向分析,评估免疫持久性和变异株特异性调节。该研究包括随时间评估抗刺突IgG和IgA水平,并分析它们与针对原始株和奥密克戎株SARS-CoV-2变异株的中和活性之间的关系。使用细胞内细胞因子染色(ICS)和激活诱导标志物(AIM)检测评估T细胞反应的持久性。抗S IgG水平随时间保持稳定,并在每次免疫刺激后升高,表明存在累积免疫记忆。中和能力与IgG水平密切相关,对于奥密克戎变异株出现之前的变异株显示出长期稳定性,但对奥密克戎变异株则有适度下降。CD4和CD8 T细胞反应在所有组中均持续存在,很大程度上不受奥密克戎突变的影响。然而,细胞因子谱显示出细微的、依赖于变异株的变化。这些发现强调了细胞免疫的持久性以及奥密克戎特异性体液反应相对较低的稳健性。这些见解对于理解针对不断演变的SARS-CoV-2变异株的长期保护以及指导公共卫生策略至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6504/12386724/b6be4ea42912/ijms-26-08106-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6504/12386724/3567b4ae87cb/ijms-26-08106-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6504/12386724/bd1c38ecc763/ijms-26-08106-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6504/12386724/b73c1ffcf3d5/ijms-26-08106-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6504/12386724/57b6490d9b87/ijms-26-08106-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6504/12386724/b6be4ea42912/ijms-26-08106-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6504/12386724/3567b4ae87cb/ijms-26-08106-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6504/12386724/bd1c38ecc763/ijms-26-08106-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6504/12386724/b73c1ffcf3d5/ijms-26-08106-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6504/12386724/57b6490d9b87/ijms-26-08106-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6504/12386724/b6be4ea42912/ijms-26-08106-g005a.jpg

相似文献

1
Long-Term Durability and Variant-Specific Modulation of SARS-CoV-2 Humoral and Cellular Immunity over Two Years.两年间 SARS-CoV-2 体液免疫和细胞免疫的长期持久性及变异株特异性调节
Int J Mol Sci. 2025 Aug 21;26(16):8106. doi: 10.3390/ijms26168106.
2
Distinct features of humoral and cellular immunity against Omicron breakthrough infection among chronic liver disease patients: An experience from a follow-up cohort.慢性肝病患者中针对奥密克戎突破性感染的体液免疫和细胞免疫的独特特征:一项随访队列研究经验
Hum Vaccin Immunother. 2025 Dec;21(1):2544466. doi: 10.1080/21645515.2025.2544466. Epub 2025 Aug 15.
3
Effective cellular and neutralizing immunity against SARS-CoV-2 after mRNA booster vaccination is associated with pDC and B cell activation.mRNA加强疫苗接种后对SARS-CoV-2产生有效的细胞免疫和中和免疫与浆细胞样树突状细胞(pDC)和B细胞活化有关。
Front Immunol. 2025 May 12;16:1580448. doi: 10.3389/fimmu.2025.1580448. eCollection 2025.
4
Humoral and Cellular Immune Responses to SARS-CoV-2 in Participants with Head and Neck Cancer.头颈癌患者对新型冠状病毒的体液免疫和细胞免疫反应
Viruses. 2025 Jun 13;17(6):848. doi: 10.3390/v17060848.
5
Long-Term Dynamics of SARS-CoV-2 Variant-Specific Neutralizing Antibodies Following mRNA Vaccination and Infection.mRNA疫苗接种和感染后SARS-CoV-2变体特异性中和抗体的长期动态变化
Viruses. 2025 May 6;17(5):675. doi: 10.3390/v17050675.
6
Comparative study of humoral and cellular immunity against SARS-CoV-2 induced by different COVID-19 vaccine types: Insights into protection against wildtype, Delta and JN.1 omicron strains.不同类型新冠疫苗诱导的针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的体液免疫和细胞免疫的比较研究:对预防野生型、德尔塔和JN.1奥密克戎毒株的见解
Vaccine. 2025 Jun 20;59:127270. doi: 10.1016/j.vaccine.2025.127270. Epub 2025 May 22.
7
Individuals Infected with SARS-CoV-2 Prior to COVID-19 Vaccination Maintain Vaccine-Induced RBD-Specific Antibody Levels and Viral Neutralization Activity for One Year.在接种新冠疫苗之前感染过新冠病毒的个体,其疫苗诱导的RBD特异性抗体水平和病毒中和活性可维持一年。
Viruses. 2025 Apr 29;17(5):640. doi: 10.3390/v17050640.
8
Co-administration of recombinant BCG and SARS-CoV-2 proteins leads to robust antiviral immunity.联合使用重组卡介苗和 SARS-CoV-2 蛋白可诱导强烈的抗病毒免疫。
Vaccine. 2024 Oct 3;42(23):126203. doi: 10.1016/j.vaccine.2024.126203. Epub 2024 Aug 22.
9
SARS-CoV-2-specific humoral and cellular immunity assessment in Peruvian vaccinated population: a cross-sectional study.秘鲁接种疫苗人群中新冠病毒特异性体液免疫和细胞免疫评估:一项横断面研究
PeerJ. 2025 Jul 15;13:e19651. doi: 10.7717/peerj.19651. eCollection 2025.
10
Monitoring of antibodies against SARS-CoV-2 over 2 years and characterization of immune responses following Omicron infection in a South Indian community cohort.在南印度一个社区队列中对2年期间抗SARS-CoV-2抗体的监测以及奥密克戎感染后免疫反应的特征分析。
Sci Rep. 2025 Jul 9;15(1):24756. doi: 10.1038/s41598-025-10447-7.

本文引用的文献

1
T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteome.T细胞表位图谱分析揭示了严重急性呼吸综合征冠状病毒2(SARS-CoV-2)蛋白质组中进化保守区域的免疫显性。
iScience. 2025 Jul 2;28(8):113044. doi: 10.1016/j.isci.2025.113044. eCollection 2025 Aug 15.
2
Comparative duration of neutralizing responses and protections of COVID-19 vaccination and correlates of protection.新冠疫苗中和抗体反应和保护作用的比较持续时间以及保护相关因素。
Nat Commun. 2025 May 22;16(1):4748. doi: 10.1038/s41467-025-60024-9.
3
Multiple infections with Omicron variants increase breadth and potency of Omicron-specific neutralizing antibodies.
感染多种奥密克戎变异株可增加奥密克戎特异性中和抗体的广度和效力。
Cell Discov. 2025 May 20;11(1):49. doi: 10.1038/s41421-025-00800-5.
4
Persistence and decay of neutralizing antibody responses elicited by SARS-CoV-2 infection and hybrid immunity in a Canadian cohort.加拿大队列中由新冠病毒感染和混合免疫引发的中和抗体反应的持久性和衰减情况。
Microbiol Spectr. 2025 Apr;13(4):e0133324. doi: 10.1128/spectrum.01333-24. Epub 2025 Feb 19.
5
Characterising the SARS-CoV-2 nucleocapsid (N) protein antibody response.表征严重急性呼吸综合征冠状病毒2(SARS-CoV-2)核衣壳(N)蛋白抗体反应。
J Infect. 2025 Mar;90(3):106436. doi: 10.1016/j.jinf.2025.106436. Epub 2025 Feb 6.
6
Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron.奥密克戎毒株出现前后对新冠病毒再感染的差异保护作用。
Nature. 2025 Mar;639(8056):1024-1031. doi: 10.1038/s41586-024-08511-9. Epub 2025 Feb 5.
7
Long-term assessment of anti-SARS-CoV-2 antibody levels post-pandemic: Tracking the dynamics after two, three, and four COVID-19 vaccine doses.大流行后抗SARS-CoV-2抗体水平的长期评估:追踪两剂、三剂和四剂新冠疫苗接种后的动态变化
J Infect Public Health. 2025 Mar;18(3):102676. doi: 10.1016/j.jiph.2025.102676. Epub 2025 Jan 19.
8
Longitudinal analysis of SARS-CoV-2 IgG antibody durability in Puerto Rico.波多黎各SARS-CoV-2 IgG抗体持久性的纵向分析。
Sci Rep. 2024 Dec 28;14(1):30743. doi: 10.1038/s41598-024-80465-4.
9
Humoral and cellular immune response to AZD1222 /Covishield and BV152/Covaxin COVID-19 vaccines among adults in India.印度成年人对 AZD1222/Covishield 和 BV152/Covaxin COVID-19 疫苗的体液和细胞免疫反应。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2410579. doi: 10.1080/21645515.2024.2410579. Epub 2024 Oct 21.
10
High-resolution kinetics and cellular determinants of SARS-CoV-2 antibody response over two years after COVID-19 vaccination.新冠疫苗接种两年后SARS-CoV-2抗体反应的高分辨率动力学及细胞决定因素
Microbes Infect. 2025 Feb;27(2):105423. doi: 10.1016/j.micinf.2024.105423. Epub 2024 Sep 17.